Growth Metrics

Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 1941.18% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 1941.18% increase, with the full-year FY2025 number at $1.7 million, up 1941.18% from a year prior.
  • Non-Current Deferred Tax Liability was $1.7 million for Q4 2025 at Lemaitre Vascular, down from $2.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.1 million in Q3 2025 to a low of $60000.0 in Q3 2022.
  • A 5-year average of $271950.0 and a median of $91500.0 in 2025 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: plummeted 89.46% in 2021, then surged 1941.18% in 2025.
  • Lemaitre Vascular's Non-Current Deferred Tax Liability stood at $70000.0 in 2021, then dropped by 1.43% to $69000.0 in 2022, then soared by 55.07% to $107000.0 in 2023, then fell by 20.56% to $85000.0 in 2024, then soared by 1941.18% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Non-Current Deferred Tax Liability are $1.7 million (Q4 2025), $2.1 million (Q3 2025), and $95000.0 (Q2 2025).